Apyx Medical Corporation
Apyx Medical Corporation (APYX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · APYX · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Apyx Medical Corporation insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
APYX insider buying and selling by quarter
APYX insider selling · APYX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · APYX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
APYX executive sell shares · APYX board member insider trading · APYX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 15, 2026 | CITRONOWICZ MOSHE SVP | Option | 37,000 | $67K | Form 4 |
| Jan 27, 2026 | Roman Shawn David COO | Option | 12,000 | $22K | Form 4 |
| Aug 13, 2024 | HILL MATTHEW C CFO | Purchase | 5,336 | $6K | Form 4 |
| Dec 12, 2023 | HILL MATTHEW C CFO | Purchase | 2,500 | $5K | Form 4 |
| Nov 14, 2023 | Goodwin Charles D. II CEO · Director | Purchase | 50,000 | $79K | Form 4 |
| Jul 12, 2023 | Waldman Lawrence Director | Option | 5,338 | $16K | Form 4 |
| Jun 26, 2023 | Hornsby Todd EVP | Option | 15,000 | $27K | Form 4 |
| Jun 26, 2023 | Hornsby Todd EVP | Sale | 15,000 | $113K | Form 4 |
| Jun 6, 2023 | Geraghty Michael Director | Option | 10,000 | $28K | Form 4 |
| Jan 7, 2022 | Swandal Craig A. Director | Option | 7,173 | $68K | Form 4 |
| Aug 29, 2022 | Goodwin Charles D. II CEO | Purchase | 9,750 | $58K | Form 4 |
| Jul 11, 2022 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Option | 30,000 | $76K | Form 4 |
| Jul 11, 2022 | Waldman Lawrence Director | Option | 24,000 | $61K | Form 4 |
| Jul 5, 2022 | MAKRIDES ANDREW Director | Option | 30,000 | $76K | Form 4 |
| Jul 5, 2022 | MAKRIDES ANDREW Director | Other | 13,583 | $83K | Form 4 |
| Jul 6, 2022 | Geraghty Michael Director | Option | 4,000 | $10K | Form 4 |
| May 19, 2022 | Waldman Lawrence Director | Option | 8,000 | $22K | Form 4 |
| May 11, 2022 | Geraghty Michael Director | Option | 6,000 | $17K | Form 4 |
| Mar 21, 2022 | Swandal Craig A. Director | Option | 17,000 | $85K | Form 4 |
Goodwin Charles D. II
CEO · Director
Date
Nov 14
Shares
50,000
Price
$1.57
Value
$79K
CITRONOWICZ MOSHE
Sr. V.P. of Operations
Date
Jul 11
Shares
30,000
Price
$2.54
Value
$76K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About APYX insider trading
APYX insider trades
Apyx Medical Corporation (APYX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CITRONOWICZ MOSHE (SVP), Roman Shawn David (COO). Over the past 12 months, 2 insiders have filed transactions with the SEC. APYX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Apyx Medical Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
APYX insider trading · 5 questionsThe insiders of Apyx Medical Corporation (APYX) include executives and directors such as CITRONOWICZ MOSHE (SVP), Roman Shawn David (COO), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026